Physician

Robert Jackson Garr, D.O.

According to 2025 Medicare claims, Robert Garr, D.O. (NPI: 1225023088) practices cardiology in the Logan, UT-ID market, with the plurality of this provider's patient population coming from Cache, UT. This provider's primary affiliated billing organization is IHC HEALTH SERVICES INC (NPI: 1801114459; TIN: 94-2854057) and primary practice location at 84341-2462. Garr is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Castell Accountable Care, LLC (ACO ID: D0136), participating under both the MSSP and REACH models.

Garr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,065 traditional Medicare patients, billed 2,258 HCPCS/CPT codes, and received $77,393 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,334 prescription claims across 592 beneficiaries totaling $442,796 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 12 claims. Open Payments data shows 6 records totaling $109. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $64,074 to $442,796. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $35,918 to $1,563.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	596	1,958	$92,667
2016	723	1,488	$62,212
2017	723	2,066	$80,827
2018	754	1,659	$79,155
2019	799	1,909	$86,500
2020	836	1,943	$79,468
2021	816	1,892	$87,642
2022	1,527	2,883	$96,468
2023	1,063	2,331	$77,716
2024	1,065	2,258	$77,393

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	174	1,666	$64,074
2016	293	1,690	$76,290
2017	270	2,195	$143,381
2018	296	2,203	$209,396
2019	312	2,272	$227,778
2020	327	2,503	$271,589
2021	357	2,439	$306,737
2022	373	2,399	$318,380
2023	482	2,645	$356,522
2024	592	3,334	$442,796

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	340	$35,280
2016	26	320	$33,237
2017	N/R	48	$10,028
2018	N/R	N/R	N/R
2019	N/R	29	$10,415
2020	N/R	35	$1,876
2021	N/R	25	$1,059
2022	N/R	12	$998
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	244	338	$84
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	107	107	$48
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	148	251	$20
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	187	214	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	485	609	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	258	11,160	$218,527
Xarelto	Rivaroxaban	149	7,210	$133,109
Farxiga	Dapagliflozin Propanediol	26	1,020	$18,959
Jardiance	Empagliflozin	19	570	$11,133
Repatha Sureclick	Evolocumab	11	308	$6,204

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$109	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Jackson Garr, D.O.?

Tedicare shows public-source Medicare data for Robert Jackson Garr, D.O. (NPI 1225023088), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Jackson Garr, D.O. have ACO affiliation data?

Robert Jackson Garr, D.O. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and Castell Accountable Care, LLC (REACH, ACO ID D0136).

What billing organization is linked to Robert Jackson Garr, D.O.?

Robert Jackson Garr, D.O. is linked to IHC HEALTH SERVICES INC (billing NPI 1801114459) in the available physician profile data.

Does Robert Jackson Garr, D.O. have Open Payments data?

Robert Jackson Garr, D.O. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.